Skip to content

STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns · Stateside Daily

Stateside DailyAll America

Search Get alerts

Home›Health›1 sources

Health · 1 sources covering this

STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns

France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1d ago
STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns
France's medicines regulator has fined Novo Nordisk and Eli Lilly over their weight loss ad campaigns.
Read at STAT →

More from Health

STAT·1d ago

Opinion: Mifepristone court ruling makes drug development riskier for everyone

NPRLean L·1d ago

Supreme Court gives abortion pill mifepristone a 1-week reprieve from a major change

Daily briefing

Stateside Daily in your inbox

The 5 stories from all america you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Stateside Daily

About
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets
Technology
Ai

STAT·1d ago

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

STAT·1d ago

Researchers urge study of paternal deaths, though a new paper finds fatherhood is protective

Reader

Notifications
Bookmarks
Search
Personal feed

Trust & legal

Corrections
Privacy
Terms
Security

Across the network

Hindustan Sphere
All India in one feed

© 2026 Stateside Daily. All headlines are sourced from third-party publishers; we never republish article bodies.

All America